Literature DB >> 9009147

Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins.

N Sang1, A Giordano.   

Abstract

By interacting with key regulatory proteins such as the pRb family, cyclins, cyclin-dependent kinases and p300/CBP of host cells, adenoviral E1A interferes with various cellular processes to provide a suitable environment for the replication of viruses. E1A may promote DNA synthesis and cell cycle progression, immortalize rodent cells in culture and transform cultured cells in cooperation with E1B, Ras, or other oncoproteins. Both extreme N terminus and conserved region 1 of E1A are required for the immortalization and the transformation of rodent cells, transcriptional repression and specific induction of the expression of cellular genes such as the proliferating cell nuclear antigen (PCNA) and heat shock protein 70 (HSP70). Although the molecular mechanisms of these functions of E1A are not fully understood, it is believed that protein-protein interactions may play essential roles. In this communication, we report that a new set of cellular proteins with apparent molecular weight of 200, 90, 45, 30, and 28 specifically associate with the extreme N terminus of E1A. Further analysis demonstrate that these associations do not depend on E1A's association with p300 or pRB. Neither the 30 kDa nor the 28 kDa polypeptide is identical to Cdc2 or Cdk2. The region of E1A required for the protein interaction is also required for the recently identified N-terminal transactivation activity of E1A. Our observations suggest that in addition to p300/CBP, the new set of cellular proteins may be involved in the functional complexity of the N terminus of E1A, thus predicting a p300/CBP independent pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009147     DOI: 10.1002/(SICI)1097-4652(199702)170:2<182::AID-JCP10>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Viral oncoproteins target the DNA methyltransferases.

Authors:  W A Burgers; L Blanchon; S Pradhan; Y de Launoit; T Kouzarides; F Fuks
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

2.  MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300.

Authors:  Nianli Sang; Daniel P Stiehl; Jolene Bohensky; Irene Leshchinsky; Vickram Srinivas; Jaime Caro
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

3.  Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.

Authors:  Daniel P Stiehl; Donna M Fath; Dongming Liang; Yubao Jiang; Nianli Sang
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

4.  Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.

Authors:  Nianli Sang; Jie Fang; Vickram Srinivas; Irene Leshchinsky; Jaime Caro
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.

Authors:  Donna M Fath; Xianguo Kong; Dongming Liang; Zhao Lin; Andrew Chou; Yubao Jiang; Jie Fang; Jaime Caro; Nianli Sang
Journal:  J Biol Chem       Date:  2006-03-15       Impact factor: 5.157

6.  A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).

Authors:  K Alevizopoulos; B Catarin; J Vlach; B Amati
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.